Unlike normal B cells that undergo apoptosis, unless they differentiate into plasma or memory cells, CLL cells represent constitutive BCR activation, which causes activation of NFκB and NFκB-regulated genes (200), induction of pro-survival signals, and production of pro-inflammatory cytokines. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.